Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 261 of 1,261
  1. US 11351190

    Composition for treating tissue lesions

    ORGANES TISSUS REGENERATION REPARATION REMPLACEMENT—OTR3 · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  2. US 11351185

    Use of isovalerylspiramycins as anti-cancer agents to inhibit metastasis

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  3. US 11351175

    Use of reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  4. US 11351161

    Use of CDK9 inhibitors to reduce cartilage degradation

    The Regents of the University of California · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  5. US 11352363

    Spiropyrrolidine derived antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  6. US 11351182

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Compass Therapeutics LLC · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  7. US 11351177

    Corticotropin releasing factor receptor antagonists

    SPRUCE BIOSCIENCES, INC. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  8. US 11351183

    Use of thyroid beta-agonists

    Viking Therapeutics, Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  9. US 11351124

    Sustained release of formulations of local anesthetics

    Eupraxia Pharmaceuticals Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  10. US 11352631

    Targeted disruption of the T cell receptor

    Sangamo Therapeutics, Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  11. US 11352639

    Gene therapy based on vector VTVAF17

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTJU “ALLEL TSENTR INNOVATSIONNYKH BIOTEKHNOLOGY” · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  12. US 11354990

    Treatment of kidney diseases associated with elevated AVP

    United States Government as represented by the Department of Veterans Affairs · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  13. US 11351120

    Use of higher doses of modified release huperzine formulations

    Supernus Pharmaceuticals, Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  14. US 11351118

    Methods for ameliorating infusion reactions

    ARBUTUS BIOPHARMA CORPORATION · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  15. US 11352446

    Methods of making multispecific antigen-binding molecules

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  16. US 11352432

    Antibodies specifically binding to human IL-1R7

    MAB Discovery GmbH · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  17. CA 3200144

    COMPOSITIONS NUTRITIONNELLES LIQUIDES AVEC FLAVONOIDE VEGETAL INSOLUBLE DANS L'EAU ET PROCEDE POUR LEUR PRODUCTION

    ABBOTT LAB [US] · Granted Jun 2, 2022 · Expires May 28, 2042

    granted
  18. US 2022169620

    SPIRO-CYCLIC AMINE DERIVATIVES AS S1P MODULATORS

    ABBVIE DEUTSCHLAND [DE] · Granted Jun 2, 2022 · Expires May 28, 2042

    granted
  19. US 11345700

    Methods of preparing inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted May 31, 2022 · Expires May 26, 2042

    granted
  20. US 11344580

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted May 31, 2022 · Expires May 26, 2042

    granted
  21. US 11344568

    Methods and compositions for administration of iron

    American Regent, Inc. · Granted May 31, 2022 · Expires May 26, 2042

    granted
  22. US 11344626

    Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use

    Sutro Biopharma, Inc. · Granted May 31, 2022 · Expires May 26, 2042

    granted
  23. US 11345894

    Cellular seeding and co-culture of a three dimensional fibroblast construct

    United States Government as represented by the Department of Veterans Affairs · Granted May 31, 2022 · Expires May 26, 2042

    granted
  24. US 11344513

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    AXSOME THERAPEUTICS, INC. · Granted May 31, 2022 · Expires May 26, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.